| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.303 | 5.766 | 5.261 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 3.315 | 5.766 | 5.262 | 0 | 0 | 0 | 1.007 | 0 | 0 | 0 |
| Total Expenses - EUR | 13.486 | 22.396 | 5.865 | 2.412 | 1.525 | 1.496 | 122 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | -10.172 | -16.630 | -603 | -2.412 | -1.525 | -1.496 | 885 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | -10.172 | -16.745 | -656 | -2.412 | -1.525 | -1.496 | 855 | 0 | 0 | 0 |
| Employees | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Novartes Project Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1 | 1 | 4.884 | 3.240 | 1.653 | 126 | 1 | 1 | 1 | 1 |
| Current Assets | 253.740 | 231.221 | 223.491 | 219.545 | 215.293 | 211.212 | 215.407 | 216.075 | 215.420 | 214.216 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 7.872 | 7.896 | 7.872 | 7.828 |
| Receivables | 161.984 | 163.000 | 163.170 | 160.332 | 157.227 | 154.246 | 151.832 | 151.293 | 150.835 | 149.992 |
| Cash | 91.756 | 68.221 | 60.320 | 59.213 | 58.067 | 56.966 | 55.702 | 56.885 | 56.713 | 56.396 |
| Shareholders Funds | -91.343 | -107.156 | -105.999 | -106.465 | -105.928 | -105.416 | -102.223 | -102.541 | -102.230 | -101.658 |
| Social Capital | 56 | 56 | 55 | 54 | 53 | 52 | 51 | 51 | 51 | 50 |
| Debts | 345.084 | 338.379 | 334.374 | 329.250 | 322.874 | 316.753 | 317.631 | 318.616 | 317.650 | 315.875 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7112 - 7112" | |||||||||
| CAEN Financial Year |
7112
|
|||||||||
Comments - Novartes Project Srl